Tissue Print Micropeels for Molecular Profiling Cancer

用于癌症分子分析的组织打印显微剥离术

基本信息

  • 批准号:
    7009613
  • 负责人:
  • 金额:
    $ 14.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Molecular profiling has emerged as an important strategy for identifying marker "signatures" associated with the biological changes that characterize specific cancers. To realize the full potential of the wealth of new biomarker information, it is essential to develop strategies for profiling human tissue and tumor specimens that are workable in a clinical setting. Clinical specimens are heterogeneous, and tissue heterogeneity is one of the major sources of complexity that must be addressed in the application of molecular profiling to the analysis of human cancers. We have developed a set of novel "tissue print" techniques that allow us to profile the molecular markers over extended areas of human tissue and tumor samples without damaging the specimen. We first applied our new tissue print techniques in the profiling of protein markers associated with capsular invasion in radical prostatectomy specimens. More recently, we have discovered that, during tissue print collection, we can peel a layer of cells off of the specimen and that this process does not cause detectable tissue damage (as determined by surgical pathologists), and thus does not interfere with routine clinical surgical pathology. We have also shown that the cells collected in the tissue print "micropeel" are adequate for PCR and quantitative rt-PCR analysis, allowing us to score multiple molecular markers and assemble the results in "tiling patterns" corresponding to the specimen surface. In the project outlined in this proposal, we will work closely with the research and development team at Qiagen Inc. to optimize the yield of mRNA and DNA from our tissue print micropeels collected from human prostate and breast tissue/tumors specimens. We will then develop a proof-of-principle pilot application of the tissue-print micropeel sampling technique for prostate needle biopsies, one of the classes of specimens that must be conserved intact for clinical diagnosis. Our long term goal is to utilize tissue print techniques in the clinical setting to simplify the process of obtaining an adequate representation of human cancers in biopsies and surgical specimens, and to develop protocols for this tissue sampling platform to support both proteomic analysis and PCR-based DNA and mRNA profiling techniques. In addition to facilitating basic and translational research, the tissue-printing platform can also be utilized as a tool for dedicated clinical applications, to provide "molecular sections" of extended areas of the specimen when the marker profile is itself of potential diagnostic importance.
描述(由申请人提供):分子谱分析已成为鉴定与表征特定癌症的生物学变化相关的标志物“签名”的重要策略。为了实现新的生物标志物信息的财富的全部潜力,它是必不可少的,以制定在临床环境中可行的人类组织和肿瘤标本的分析策略。临床标本是异质性的,组织异质性是复杂性的主要来源之一,必须解决在应用分子谱分析人类癌症的分析。我们已经开发了一套新的“组织打印”技术,使我们能够在不损坏标本的情况下,在人体组织和肿瘤样本的扩展区域上描绘分子标记。我们首先应用我们的新的组织打印技术在蛋白质标记物的分析与包膜浸润在根治性膀胱癌切除术标本。最近,我们发现,在组织印迹收集过程中,我们可以从标本上剥离一层细胞,并且该过程不会引起可检测的组织损伤(由外科病理学家确定),因此不会干扰常规临床外科病理学。我们还表明,在组织打印“micropeel”中收集的细胞足以进行PCR和定量rt-PCR分析,使我们能够对多个分子标记进行评分,并将结果组装成与标本表面相对应的“平铺模式”。 在本提案中概述的项目中,我们将与Qiagen Inc.的研发团队密切合作。优化从我们的组织打印微片(从人前列腺和乳腺组织/肿瘤标本中收集)中mRNA和DNA的产量。然后,我们将开发用于前列腺穿刺活检的组织打印微剥离取样技术的原理验证试点应用,这是必须完整保存以用于临床诊断的样本类别之一。我们的长期目标是在临床环境中利用组织打印技术,以简化在活检和手术标本中获得人类癌症的充分代表性的过程,并为该组织采样平台开发协议,以支持蛋白质组学分析和基于PCR的DNA和mRNA分析技术。除了促进基础和转化研究之外,组织打印平台还可以用作专用临床应用的工具,以在标记物谱本身具有潜在诊断重要性时提供样本的扩展区域的“分子切片”。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.
  • DOI:
    10.1007/s10334-008-0133-3
  • 发表时间:
    2008-11
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Lenkinski, Robert E.;Bloch, B. Nicolas;Liu, Fangbing;Frangioni, John V.;Perner, Sven;Rubin, Mark A.;Genega, Elizabeth M.;Rofsky, Neil M.;Gaston, Sandra M.
  • 通讯作者:
    Gaston, Sandra M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANDRA M GASTON其他文献

SANDRA M GASTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANDRA M GASTON', 18)}}的其他基金

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection
富含 PSMA 的细胞外囊泡用于前列腺癌检测的严谨性和临床实用性
  • 批准号:
    10745084
  • 财政年份:
    2023
  • 资助金额:
    $ 14.28万
  • 项目类别:
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness
前列腺针活检:分析前采购和处理变量对前列腺癌侵袭性基因表达特征检测的影响
  • 批准号:
    10457135
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness
前列腺针活检:分析前采购和处理变量对前列腺癌侵袭性基因表达特征检测的影响
  • 批准号:
    10649631
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals
前列腺癌中的胆碱代谢:对膳食大豆植物化学物质的反应
  • 批准号:
    7498522
  • 财政年份:
    2007
  • 资助金额:
    $ 14.28万
  • 项目类别:
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals
前列腺癌中的胆碱代谢:对膳食大豆植物化学物质的反应
  • 批准号:
    7314704
  • 财政年份:
    2007
  • 资助金额:
    $ 14.28万
  • 项目类别:
Prostate MRI and MRS: Correlations with Gene Expression
前列腺 MRI 和 MRS:与基因表达的相关性
  • 批准号:
    7096391
  • 财政年份:
    2006
  • 资助金额:
    $ 14.28万
  • 项目类别:
Prostate MRI and MRS: Correlations with Gene Expression
前列腺 MRI 和 MRS:与基因表达的相关性
  • 批准号:
    7230220
  • 财政年份:
    2006
  • 资助金额:
    $ 14.28万
  • 项目类别:
Tissue Print Micropeels for Molecular Profiling Cancer
用于癌症分子分析的组织打印显微剥离术
  • 批准号:
    6862319
  • 财政年份:
    2005
  • 资助金额:
    $ 14.28万
  • 项目类别:
REGULATION OF CELLULAR DIFFERENTIATION: CHOLINESTERASE
细胞分化的调节:胆碱酯酶
  • 批准号:
    3053998
  • 财政年份:
    1986
  • 资助金额:
    $ 14.28万
  • 项目类别:
REGULATION OF CELLULAR DIFFERENTIATION: CHOLINESTERASE
细胞分化的调节:胆碱酯酶
  • 批准号:
    3053997
  • 财政年份:
    1985
  • 资助金额:
    $ 14.28万
  • 项目类别:

相似海外基金

DCTD - Image Annotation for NCI Clinical Research Databases
DCTD - NCI 临床研究数据库的图像注释
  • 批准号:
    10273264
  • 财政年份:
    2020
  • 资助金额:
    $ 14.28万
  • 项目类别:
IMAGE ANNOTATION FOR NCI CLINICAL RESEARCH DATABASES
NCI 临床研究数据库的图像注释
  • 批准号:
    10281351
  • 财政年份:
    2020
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    8924174
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    8733168
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    8914614
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    8628397
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    9310239
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
  • 批准号:
    9130499
  • 财政年份:
    2013
  • 资助金额:
    $ 14.28万
  • 项目类别:
Nephrotic Syndrome Rare Disease Clinical Research Network
肾病综合征罕见病临床研究网
  • 批准号:
    8764274
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:
Nephrotic Syndrome Rare Disease Clinical Research Network III
肾病综合征罕见病临床研究网络III
  • 批准号:
    10017205
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了